Longeveron (LGVN) Other Non Operating Income (2020 - 2026)

Longeveron (LGVN) recorded quarterly Other Non Operating Income of $39000.0 in Q1 2026, down 25.0% quarter-over-quarter from $52000.0 in Q4 2025, and down 77.06% on a YoY basis from $170000.0 in Q1 2025.

Longeveron (LGVN) Other Non Operating Income (2020 - 2026) Analysis & Trends

Longeveron's Other Non Operating Income history runs 7 years deep, the most recent figure standing at $39000.0 for Q1 2026.

  • In Q1 2026, Other Non Operating Income fell 77.06% year-over-year to $39000.0; the TTM figure through Mar 2026 stood at $549000.0 (down 20.09% YoY), while the FY2025 annual figure was $680000.0, up 23.86% from the prior year.
  • Other Non Operating Income was $39000.0 for Q1 2026 at Longeveron, down from $52000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $1.9 million in Q4 2022 to a low of -$1.4 million in Q2 2022.
  • Historically, Other Non Operating Income has averaged $70058.8 across 5 years, with a median of $69000.0 in 2023.
  • Biggest YoY gain for Other Non Operating Income was 5170.27% in 2022; the steepest drop was 2798.08% in 2022.
  • A 5-year view of Other Non Operating Income shows it stood at $1.9 million in 2022, then slumped by 130.97% to -$581000.0 in 2023, then surged by 134.42% to $200000.0 in 2024, then slumped by 74.0% to $52000.0 in 2025, then decreased by 25.0% to $39000.0 in 2026.
  • The last three Other Non Operating Income figures came in at $39000.0 (Q1 2026), $52000.0 (Q4 2025), and $89000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Longeveron 20.35 Bn 20.33 Bn 264,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 39,000.00
Dec 31, 2025 52,000.00
Sep 30, 2025 89,000.00
Jun 30, 2025 369,000.00
Mar 31, 2025 170,000.00
Dec 31, 2024 200,000.00
Sep 30, 2024 230,000.00
Jun 30, 2024 87,000.00
Mar 31, 2024 32,000.00
Dec 31, 2023 -581,000.00
Sep 30, 2023 55,000.00
Jun 30, 2023 80,000.00
Mar 31, 2023 69,000.00
Dec 31, 2022 1.88 Mn
Sep 30, 2022 -57,000.00
Jun 30, 2022 -1.40 Mn
Mar 31, 2022 -116,000.00
Dec 31, 2021 -37,000.00
Sep 30, 2021 50,000.00
Jun 30, 2021 52,000.00